Simone Koole, MD, on Ovarian Cancer: Results of the OVHIPEC Trial

2017 ESMO Congress
Tweet this page

Simone Koole, MD (and a PhD candidate), of the Netherlands Cancer Institute, discusses phase III findings on health-related quality of life after hyperthermic intraperitoneal chemotherapy for stage III ovarian cancer.

Advertisement

Advertisement



Advertisement